Bill > HB4422

This bill prohibits health benefit plan issuers, pharmacy benefit managers, and third-party payors from discriminating against entities participating in the federal 340B Drug Discount Program (covered entities), which helps certain healthcare providers obtain discounted drugs. Specifically, the bill prevents these organizations from reimbursing covered entities at lower rates compared to non-covered entities for the same prescription drug, imposing different or additional terms on covered entities (such as unique fees or network participation requirements), or creating restrictions for patients who choose to receive prescription drugs from a covered entity. The bill applies to a wide range of health benefit plans, including various types of insurance policies, state programs like Medicaid and the child health plan program, and health coverage offered by entities such as school districts and county employers. The new provisions will take effect for health benefit plans delivered, issued, or renewed on or after January 1, 2026, with the entire act becoming effective on September 1, 2025. The legislation aims to ensure fair treatment of healthcare providers participating in the 340B Drug Discount Program by preventing discriminatory practices that could potentially limit access to affordable medications.

Business and Industry

https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB4422